# Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis

> **NCT05933213** · PHASE4 · UNKNOWN · sponsor: **Xiangya Hospital of Central South University** · enrollment: 205 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Mescaline sodium enteric-coated tablets
- **DRUG:** Morte-mescaline
- **DRUG:** Glucocorticoids

## Key facts

- **NCT ID:** NCT05933213
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-06
- **Primary completion:** 2025-07
- **Final completion:** 2025-12
- **Target enrollment:** 205 (ESTIMATED)
- **Last updated:** 2023-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05933213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05933213, "Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05933213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*